- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07711821
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care (PRIMARY-HF)
PRIMARY-HF: Diagnóstico de Insuficiência Cardíaca em Cuidados de Saúde Primários Utilizando Ecografia Point-of-Care e Péptidos Natriuréticos
The goal of this clinical trial is to evaluate whether the use of NT-proBNP testing and point-of-care ultrasound (POCUS) can improve the diagnosis and management of heart failure in adults aged 50 years or older with suspected heart failure or cardiovascular risk factors in primary care settings.
The main questions it aims to answer are:
- Does the use of NT-proBNP and/or POCUS increase the rate of new heart failure diagnoses compared with standard care?
- Does this approach support earlier initiation of guideline-directed medical therapy and improve patients' quality of life?
Researchers will compare standard care alone with standard care combined with NT-proBNP testing, POCUS, or both, to assess their impact on diagnosis and management of heart failure.
Participants will:
- Be randomly assigned to one of four groups (standard care, NT-proBNP, POCUS, or both).
- Undergo clinical evaluation for heart failure according to their assigned group.
- Be followed for 12 months with periodic assessments of quality of life and treatment adherence.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Jonathan dos Santos, MD.
- Correo electrónico: jonathan.santos@ua.pt
Ubicaciones de estudio
-
-
-
Amadora, Portugal
- Aún no reclutando
- Unidade de Saúde Familiar Conde da Lousã
-
Contacto:
- Miguel Henriques
- Número de teléfono: (+351) 914 338 519
- Correo electrónico: miguelcachinho@gmail.com
-
Lisbon, Portugal
- Aún no reclutando
- Unidade de Saúde Familiar do Parque
-
Contacto:
- Joana Gonçalves
- Número de teléfono: (+351) 961 703 789
- Correo electrónico: joana.goncalves@ulssm.min-saude.pt
-
Lisbon, Portugal
- Aún no reclutando
- Unidade de Saúde Familiar Rodrigues Miguéis
-
Contacto:
- Inês Santos
- Número de teléfono: (+351) 911 178 033
- Correo electrónico: inessalmeidasantos@gmail.com
-
Porto, Portugal
- Reclutamiento
- Unidade de Saúde Familiar Garcia Orta
-
Contacto:
- Rita Queirós
- Número de teléfono: (+351) 917 257 162
- Correo electrónico: queiros.rita.ana@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adults aged ≥50 years
- Suspected heart failure (based on signs and/or symptoms) OR
Presence of at least two cardiovascular risk factors, including:
- Diabetes mellitus
- Arterial hypertension
- Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m²
- Albuminuria
- Coronary artery disease or prior myocardial infarction or coronary revascularization
- Stroke or transient ischemic attack
- Atrial fibrillation or flutter
- Left ventricular hypertrophy or Q waves on electrocardiogram
- Obesity (body mass index ≥30 kg/m²)
- Ability to provide written informed consent
Exclusion Criteria:
- Known heart failure under active hospital-based follow-up
- Terminal illness or life expectancy <1 year
- Severe comorbid conditions limiting participation or follow-up
- Inability to provide informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Standard of care
Participants receive standard clinical evaluation and management in primary care without NT-proBNP testing and without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
|
|
Comparador activo: Standard of care + NT-proBNP
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing, but without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
|
|
Experimental: Standard of care + NT-proBNP + POCUS
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing and cardiac point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
|
Experimental: Standard of care + POCUS
Participants receive standard clinical evaluation and management in primary care with cardiac point-of-care ultrasound (POCUS), but without NT-proBNP testing.
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
New Heart Failure Diagnosis
Periodo de tiempo: From baseline to 12 months
|
Proportion of participants with a new diagnosis of heart failure established during follow-up based on clinical evaluation and diagnostic testing according to routine practice.
|
From baseline to 12 months
|
|
Initiation of Guideline-Directed Medical Therapy (GDMT)
Periodo de tiempo: From baseline to 12 months
|
Proportion of participants in whom guideline-directed medical therapy for heart failure is initiated during follow-up.
|
From baseline to 12 months
|
|
Change in Health-Related Quality of Life (KCCQ-12)
Periodo de tiempo: From baseline to 12 months
|
Change from baseline in health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) score.
|
From baseline to 12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cost-effectiveness of diagnostic strategies
Periodo de tiempo: From baseline to 12 months
|
Evaluation of the cost-effectiveness of diagnostic strategies incorporating NT-proBNP testing and/or point-of-care ultrasound (POCUS), including direct healthcare costs (e.g., diagnostic testing and referrals) and indirect costs (e.g., patient time and productivity loss).
|
From baseline to 12 months
|
|
Quality of Cardiac POCUS Examinations
Periodo de tiempo: From baseline to 12 months
|
Assessment of the quality and interpretability of cardiac point-of-care ultrasound (POCUS) examinations performed by trained primary care physicians, based on expert review.
|
From baseline to 12 months
|
|
Healthcare Resource Utilization
Periodo de tiempo: From baseline to 12 months
|
Assessment of healthcare resource utilization, including the number of conventional echocardiograms performed and referrals to specialist care.
|
From baseline to 12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Jonathan dos Santos, Aveiro University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PRIMARY-HF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .